Bank Pictet & Cie (Europe)’s Twist Bioscience TWST Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,155	Closed	-$255K	–	178
2022 Q1	$255K	Buy	5,155 +487	+10%	+$27K	0.01%	151
2021 Q4	$361K	Buy	4,668 +2,134	+84%	+$219K	0.01%	141
2021 Q3	$271K	Buy	+2,534	New	+$290K	0.01%	150

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s TWST Position: Q2 2022 in Review

Bank Pictet & Cie (Europe) sold out of Twist Bioscience (TWST) in Q2 2022, closing a stake of 5,155 shares — an estimated $255K sold.

Bank Pictet & Cie (Europe) first reported a position in TWST in Q3 2021 and held it in 3 quarters. The position peaked at $361K in Q4 2021. 205 funds tracked by Wall St. Rank hold TWST as of Q2 2022.

Bank Pictet & Cie (Europe) reported no remaining Twist Bioscience position as of Q2 2022 after selling out during the quarter.
Bank Pictet & Cie (Europe) sold 5,155 Twist Bioscience shares in Q2 2022, an estimated $255K.
Bank Pictet & Cie (Europe) first reported a position in Twist Bioscience in Q3 2021 and held it in 3 quarters.
Bank Pictet & Cie (Europe)'s Twist Bioscience position peaked at $361K in Q4 2021.
205 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2022.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2022, filed 5 Aug 2022.